Table 4.
Summary table of the ANOVA applied to protocol 3 data
| Trial type | TPJ |
hMT/V5+ |
Sham TMS |
||||||
|---|---|---|---|---|---|---|---|---|---|
| ΔTE ± SEM (ms) | TMS F(1,20) | TMS × MD F(3,20) | ΔTE ± SEM (ms) | TMS F(1,20) | TMS × MD F(3,20) | ΔTE ± SEM (ms) | TMS F(1,20) | TMS × MD F(3,20) | |
| TMS-100 | |||||||||
| −g | −9.8 (6.1) | 2.6 | 1.0 | −25.0 (3.4) | 26.7** | 1.1 | 6.6 (5.2) | 2.1 | 3.0 |
| g | −19.7 (4.9) | 14.6** | 0.34 | −32.3 (4.6) | 50.1** | 0.61 | −4.9 (5.7) | 0.65 | 0.13 |
| TMS-300 | |||||||||
| −g | 0.85 (8.9) | 0.01 | 0.44 | −12.7 (7.8) | 2.6 | 0.76 | −3.4 (6.0) | 0.29 | 0.15 |
| g | −4.8 (6.9) | 0.48 | 1.1 | −5.1 (6.6) | 0.7 | 2.4 | −4.8 (3.7) | 1.8 | 1.9 |